Oral Contraceptive Use and Colorectal Cancer in the Nurses' Health Study I and II | Citedby Results | Cancer Epidemiology, Biomarkers & Prevention | American Association for Cancer Research

Skip to Main Content

Skip Nav Destination

Oral Contraceptive Use and Colorectal Cancer in the Nurses' Health Study I and II

Cancer Epidemiol Biomarkers Prev (2015) 24 (8): 1214–1221.

This article has been cited by the following articles in journals that are participating in CrossRef Cited-by Linking.

Cancer risk factors associated with historical contraceptive use and breastfeeding duration

Pipit Feriani
Esti Yunitasari
Ferry Efendi
Ilya Krisnana
Rini Ernawati
Reny Mareta Sari
Nurus Safaah

Healthcare in Low-resource Settings (2023)

Medication use and risk of proximal colon cancer: a systematic review of prospective studies with narrative synthesis and meta-analysis

Rhea Harewood
Ruth Disney
James Kinross
Christian von Wagner
Amanda J. Cross

Cancer Causes & Control (2021) 32 (10): 1047.

Plasma sex hormones and risk of conventional and serrated precursors of colorectal cancer in postmenopausal women

Dong Hang
Xiaosheng He
Ane Sørlie Kværner
Andrew T. Chan
Kana Wu
Shuji Ogino
Zhibin Hu
Hongbing Shen
Edward L. Giovannucci
Mingyang Song

BMC Medicine (2021) 19 (1)

Endogenous Progestogens and Colorectal Cancer Risk among Postmenopausal Women

Kara A. Michels
Ashley M. Geczik
Doug C. Bauer
Louise A. Brinton
Diana S.M. Buist
Jane A. Cauley
Cher M. Dallal
Roni T. Falk
Trisha F. Hue
James V. Lacey
Andrea Z. LaCroix
Jeffrey A. Tice
Xia Xu
Britton Trabert

Cancer Epidemiology, Biomarkers & Prevention (2021) 30 (6): 1100.

Theoretical potential for endometrial cancer prevention through primary risk factor modification: Estimates from the EPIC cohort

International Journal of Cancer (2020) 147 (5): 1325.

Hormonal and reproductive factors and reduction in the risk of colorectal cancer

Gad Rennert
Hedy S. Rennert
Mila Pinchev
Stephen B. Gruber
Ofer Lavie

European Journal of Cancer Prevention (2020) 29 (3): 229.

Risk factors for colorectal cancer significantly vary by anatomic site

Joshua Demb
Ashley Earles
María Elena Martínez
Ranier Bustamante
Alex K Bryant
James D Murphy
Lin Liu
Samir Gupta

BMJ Open Gastroenterology (2019) 6 (1): e000313.

Hormone replacement therapies, oral contraceptives, reproductive factors and colorectal adenoma risk: a systematic review and dose–response meta‐analysis of observational studies

J. Song
Z. Jin
H. Han
M. Li
Y. Guo
H. Guo
W. Guo
J. He

Colorectal Disease (2019) 21 (7): 748.

Association of Combined Estrogen–Progestogen and Progestogen-Only Contraceptives with the Development of Cancer

William V. Williams
Louise A. Mitchell
S. Kathleen Carlson
Kathleen M. Raviele

The Linacre Quarterly (2018) 85 (4): 412.

The role of pregnancy, perinatal factors and hormones in maternal cancer risk: a review of the evidence

R. Troisi
T. Bjørge
M. Gissler
T. Grotmol
C. M. Kitahara
S. M. Myrtveit Sæther
A. G. Ording
C. Sköld
H. T. Sørensen
B. Trabert
I. Glimelius

Journal of Internal Medicine (2018) 283 (5): 430.

Assessing the Role of Reversible Contraceptives in the Health Care of Women as it Pertains to Cancer Prevention

Carolyn M. Ross
Lee P. Shulman

Advances in Therapy (2017) 34 (11): 2412.

Reproductive factors and risk of colorectal polyps in a colonoscopy-based study in western Washington State

Sheetal Hardikar
Andrea N. Burnett-Hartman
Jessica Chubak
Melissa P. Upton
Lee-Ching Zhu
John D. Potter
Polly A. Newcomb

Cancer Causes & Control (2017) 28 (3): 241.

Exogenous Hormone Use: Oral Contraceptives, Postmenopausal Hormone Therapy, and Health Outcomes in the Nurses’ Health Study

Shilpa N. Bhupathiraju
Francine Grodstein
Meir J. Stampfer
Walter C. Willett
Frank B. Hu
JoAnn E. Manson

American Journal of Public Health (2016) 106 (9): 1631.